Conflict of interest in clinical practice

Chest

Volumn 132, Issue 2, 2007, Pages 664-670

  Tonelli, Mark R ^a,b  

^a UNIVERSITY OF WASHINGTON   (United States)

^b Box 356522 ^*  (United States)

Author keywords

Conflict of interest; Disclosure; Ethics

Indexed keywords

CLINICAL PRACTICE; CONFLICT OF INTEREST; DEVICE; ETHICS; FINANCIAL MANAGEMENT; HUMAN; INTERPERSONAL COMMUNICATION; MEDICAL DECISION MAKING; MEDICAL EDUCATION; MEDICAL PRACTICE; PRACTICE GUIDELINE; PRIORITY JOURNAL; REVIEW;

EID: 34548043755     PISSN: 00123692     EISSN: None     Source Type: Journal    
DOI: 10.1378/chest.07-0315     Document Type: Article

References (53)

1. Pellegrino E, Thomasma D. For the patient's good: the restoration of beneficence in health care. New York, NY: Oxford University Press, 1988
2. Levinsky N. The doctor's master. N Engl J Med 1984; 325:1666-1671
3. Stell L. Two cheers for physicians' conflicts of interest. Mt Sinai J Med 2004; 71:236-242
4. Thompson D. Understanding financial conflicts of interest. N Engl J Med 1993; 329:573-576
5. McDowell TJ. Physician self referral arrangements: legitimate business or unethical "entrepreneurialism." Am J Law Med 1989; 15:61-109
6. Moore N. Entrepreneurial doctors and lawyers: regulating business activity in the medical and legal professions. In: Spece R, Shimm D, Buchanan A, eds. Conflicts of interest in clinical practice and research. New York, NY: Oxford University Press, 1996; 171-196
7. Kouri B, Parsons R, Alpert H. Physician self-referral for diagnostic imaging: review of the empiric literature. AJR Am J Roentgenol 2002; 179:843-850
8. Mitchell J, Sass T. Physician ownership of ancillary services: indirect demand inducement or quality assurance? J Health Econ 1995; 14:263-289
9. Nallamothu B, Rogers M, Chernew M, et al. Opening of specialty cardiac hospitals and use of coronary revascularization in Medicare beneficiaries. JAMA 2007; 297:962-968
10. Todd J, Horan J. Physician referral: the AMA view. JAMA 1989; 262:395-396
11. Stark F. Physicians' conflict in patient referrals. JAMA 1989; 262:397
12. Moore N. Regulating self-referrals and other physician conflicts of interest. HEC Forum 2003; 15:134-154
13. Morreim E. Conflicts of interest: profits and problems. JAMA 1989; 262:390-394
14. Rodwin M. Physicians' conflicts of interest in HMOs and hospitals. In: Spece R, Shimm D, Buchanan A, eds. Conflicts of interest in clinical practice and research. New York, NY: Oxford University Press, 1996; 197-227
15. Brody H, Bonham VJ. Gag rules and trade secrets in managed care contracts: ethical and legal concerns. Arch Intern Med 1997; 157:2037-2043
16. Freudenheim M. Company clinics cut health costs. NY Times 2007; January 14, 2007:1
17. Hillman A. Financial incentives for physicians in HMOs: is there a conflict of interest? N Engl J Med 1987; 317:1743-1748
18. Berwick D. The toxicity of pay for performance. Qual Manag Health Care 1995; 4:27-33
19. Petersen L, Woodard L, Urech T, et al. Does pay-for-performance improve the quality of health care? Ann Intern Med 2006; 145:265-272
20. Angell M. The truth about drug companies. New York, NY: Random House, 2004
21. Kassirer J. On the take: how medicine's complicity with big business can endanger your health. New York, NY: Oxford University Press, 2004
22. Blumenthal D. Doctors and drug companies. N Engl J Med 2004; 351:1885-1890
23. Moynihan R. Who pays for the pizza? Redefining the relationships between doctors and drug companies: 1. Entanglement. BMJ 2003; 326:1189-1192
24. Gibbons RV, Landry FJ, Blouch DL, et al. A comparison of physicians' and patients' attitudes toward pharmaceutical industry gifts. J Gen Intern Med 1998; 13:151-154
25. Blake RL Jr, Early EK. Patients' attitudes about gifts to physicians from pharmaceutical companies. J Am Board Fam Pract 1995; 8:457-464
26. Spilker B. The benefits and risks of a pack of M&Ms. Health Aff (Millwood) 2002; 21:243-244
27. McKinney W, Schiedermayer D, Lurie N, et al. Attitudes of internal medicine faculty and residents toward professional interaction with pharmaceutical sales represtatives. JAMA 1990; 264:1693-1697
28. Steinman MA, Shlipak MG, McPhee SJ. Of principles and pens: attitudes and practices of medicine housestaff toward pharmaceutical industry promotions. Am J Med 2001; 110:551-557
29. Katz D, Caplan AL, Merz JF. All gifts large and small: toward an understanding of the ethics of pharmaceutical industry gift-giving. Am J Bioeth 2003; 3:39-46
30. Wazana A. Physicians and the pharmaceutical industry: is a gift ever just a gift? JAMA 2000; 283:373-380
31. Orlowski JP, Wateska L. The effects of pharmaceutical firm enticements on physician prescribing patterns: there's no such thing as a free lunch. Chest 1992; 102:270-273
32. Wazana A, Primeau F. Ethical considerations in the relationship between physicians and the pharmaceutical industry. Psychiatr Clin North Am 2002; 25(3):647-663, viii
33. Studdert DM, Mello MM, Brennan TA. Financial conflicts of interest in physicians' relationships with the pharmaceutical industry: self-regulation in the shadow of federal prosecution. N Engl J Med 2004; 351:1891-1900
34. Drazen JM, Curfman GD. Financial associations of authors. N Engl J Med 2002; 346:1901-1902
35. Kahn JM, Goitein L. Pharmaceutical industry sponsorship of journal supplements [letter]. Chest 2006; 129:1387
36. Choudhry NK, Stelfox HT, Detsky AS. Relationships between authors of clinical practice guidelines and the pharmaceutical industry. JAMA 2002; 287:612-617
37. Accreditation Council for Continuing Medical Education. Annual report data 2005. 2005. Available at: http://www.accme.org/dir_docs/doc_upload/ 9c795f02-c470-4ba3-a491-d288be965eff_uploaddocument.pdf. Accessed January 10, 2007
38. Relman AS. Separating continuing medical education from pharmaceutical marketing. JAMA 2001; 285:2009-2012
39. Elliott C. Pharma goes to the laundry: public relations and the business of medical education. Hastings Cent Rep 2004; 34:18-23
40. Holmer AF. Industry strongly supports continuing medical education. JAMA 2001; 285:2012-2014
41. Eichacker PQ, Natanson C, Danner RL. Surviving sepsis: practice guidelines, marketing campaigns, and Eli Lilly. N Engl J Med 2006; 355:1640-1642
42. American College of Chest Physicians Health and Science Policy Committee. Conflict of interest policy for guideline development 2005. Available at: http://www.chestnet.org/downloads/education/guidelines/development/ COI_HSPpolicy.pdf. Accessed May 25, 2007
43. Steinbrook R. Commercial support and continuing medical education. N Engl J Med 2005; 352:534-535
44. Katz HP, Goldfinger SE, Fletcher SW. Academia-industry collaboration in continuing medical education: description of two approaches. J Contin Educ Health Prof 2002; 22:43-54
45. Bowman MA, Pearle DL. Changes in drug prescribing patterns related to commercial company funding of continuing medical education. J Contin Educ Health Prof 1988; 8:13-20
46. Accreditation Council for Continuing Medical Education. Standards for commercial support 2004. Available at: http://www.accme.org/dir_docs/doc_upload/ 68b2902a-fb73-44d1-8725-80a1504e520c_uploaddocument.pdf. Accessed January 10, 2007
47. Relman A. Defending professional independence: ACCME's proposed new guidelines for commercial support of CME. JAMA 2003; 289:2418-2420
48. Accreditation Council for Continuing Medical Education. United States Senate request for information from the ACCME 2006. Available at: http://www.accme.org/dir_docs/doc_upload/f246abd5-71b8-4b6a-b82d- ffe7689665e9_uploaddocument.pdf. Accessed January 12, 2007
49. Brennan TA, Rothman DJ, Blank L, et al. Health industry practices that create conflicts of interest: a policy proposal for academic medical centers. JAMA 2006; 295:429-433
50. Coleman DL, Kazdin AE, Miller LA, et al. Guidelines for interactions between clinical faculty and the pharmaceutical industry: one medical school's approach. Acad Med 2006; 81:154-160
51. Hayes TM, Allery LA, Harding KG, et al. Continuing education for general practice and the role of the pharmaceutical industry. Br J Gen Pract 1990; 40:510-512
52. Medical professionalism in the new millennium: a physician charter. Ann Intern Med 2002; 136:243-246
53. Rodwin MA. Physicians' conflicts of interest: the limitations of disclosure. N Engl J Med 1989; 321:1405-1408